Adicet Bio's three largest insider shareholders as of August 04, 2026 are Capital Management, L.P. Ra (TenPercentOwner, 1.18Mn shares), Advisors Llc Orbimed (TenPercentOwner, 280.64K shares), Aya Jakobovits (Director, 22.27K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Advisors Llc Orbimed | - | 0 | 280,641 | 10 Oct, 2025 |
| Chen Schor | President Ceo | 0 | 2,717 | 02 Oct, 2023 |
| Capital Management, L.P. Ra | - | 0 | 1,182,624 | 13 Apr, 2026 |
| Michael Kauffman | - | 369 | 0 | 07 Jun, 2024 |
| Jeffrey Chodakewitz | - | 1,106 | 0 | 13 Jun, 2025 |
| Don Healey | Chief Technology Officer | 3,452 | 0 | 27 Jan, 2026 |
| Aya Jakobovits | - | 0 | 22,272 | 11 Mar, 2022 |
| Blake Aftab | Chief Scientific Officer | 2,981 | 0 | 27 Jan, 2026 |
| Katie Peng | - | 738 | 0 | 13 Jun, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 18 Feb, 2026 | Capital Management, L.P. Ra | Common Stock | A | 74,577 | $7.04 | 1,033,605 | I | P |
| 19 Feb, 2026 | Capital Management, L.P. Ra | Common Stock | A | 74,268 | $7.21 | 1,107,873 | I | P |
| 20 Feb, 2026 | Capital Management, L.P. Ra | Common Stock | A | 74,751 | $7.27 | 1,182,624 | I | P |
| 07 Apr, 2026 | Advisors Llc Orbimed | Common Stock | D | 29,319 | $6.53 | 34,923 | I | S |
| 07 Apr, 2026 | Advisors Llc Orbimed | Common Stock | D | 2,400 | $6.38 | 32,523 | I | S |
| 08 Apr, 2026 | Advisors Llc Orbimed | Common Stock | D | 32,523 | $6.29 | 0 | I | S |
| 08 Apr, 2026 | Advisors Llc Orbimed | Common Stock | D | 40,416 | $6.52 | 0 | I | S |
| 25 Mar, 2026 | Blake Aftab | Stock Option (Right to Buy) | A | 72,555 | $0.00 | 72,555 | D | A |
| 25 Mar, 2026 | Blake Aftab | Stock Option (Right to Buy) | A | 72,555 | $0.00 | 72,555 | D | A |
| 25 Mar, 2026 | Julia D. Maltzman | Stock Option (Right to Buy) | A | 72,555 | $0.00 | 72,555 | D | A |
| 25 Mar, 2026 | Julia D. Maltzman | Stock Option (Right to Buy) | A | 72,555 | $0.00 | 72,555 | D | A |
| 25 Mar, 2026 | Blake Aftab | Stock Option (Right to Buy) | A | 72,555 | $0.00 | 72,555 | D | A |
| 25 Mar, 2026 | Julia D. Maltzman | Stock Option (Right to Buy) | A | 72,555 | $0.00 | 72,555 | D | A |
| 25 Mar, 2026 | Blake Aftab | Stock Option (Right to Buy) | A | 72,555 | $0.00 | 72,555 | D | A |
| 25 Mar, 2026 | Blake Aftab | Stock Option (Right to Buy) | A | 72,555 | $0.00 | 72,555 | D | A |
| 25 Mar, 2026 | Don Healey | Stock Option (Right to Buy) | A | 43,361 | $0.00 | 43,361 | D | A |
| 25 Mar, 2026 | Julia D. Maltzman | Stock Option (Right to Buy) | A | 72,555 | $0.00 | 72,555 | D | A |
| 25 Mar, 2026 | Chen Schor | Stock Option (Right to Buy) | A | 468,555 | $0.00 | 468,555 | D | A |
| 25 Mar, 2026 | Julia D. Maltzman | Stock Option (Right to Buy) | A | 72,555 | $0.00 | 72,555 | D | A |
| 24 Jan, 2026 | Blake Aftab | Common Stock | D | 535 | $8.44 | 2,981 | D | F |